ZIOPHARM Oncology, Inc.
(NASDAQ : ZIOP)

( )
ZIOP After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.66%196.941.3%$565.97m
GILDGilead Sciences, Inc.
0.70%66.420.9%$368.71m
BIIBBiogen Inc.
1.35%238.791.3%$340.32m
ILMNIllumina, Inc.
1.43%309.573.5%$338.07m
ALXNAlexion Pharmaceuticals, Inc.
0.62%106.322.0%$332.28m
CELGCelgene Corporation
0.42%99.371.3%$309.99m
REGNRegeneron Pharmaceuticals, Inc.
3.40%295.872.6%$188.33m
VRTXVertex Pharmaceuticals Incorporated
1.12%178.121.9%$186.01m
AAgilent Technologies, Inc.
-0.18%77.931.6%$185.14m
EXASExact Sciences Corporation
0.55%103.9724.1%$152.91m
SRPTSarepta Therapeutics, Inc.
-3.34%82.5114.6%$139.60m
ACADACADIA Pharmaceuticals Inc.
-2.26%40.7413.9%$129.03m
INCYIncyte Corporation
3.96%81.212.5%$93.98m
ALDRAlder Biopharmaceuticals, Inc.
-0.11%18.6410.2%$81.98m
BMRNBioMarin Pharmaceutical Inc.
-1.38%74.954.3%$76.08m

Company Profile

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of a diverse portfolio of cancer therapies. It focuses on developing products in immuno-oncology that employ novel gene expression, control, and cell technologies for the treatment of cancer. The company was founded on September 9, 2003 and is headquartered in Boston, MA.